Abstract. The various associations of motor and non-motor symptoms, the onset of motor complications, the cognitive disorder's appearance and other factors make Parkinson's disease (PD) a heterogeneous syndrome with multiple phenotypes. The necessity of discriminating between different forms of PD could have a role in understanding the pathophysiology of extrapyramidal signs with clinical implications. The aim of this study was to evaluate if there is a relationship between the clinical motor phenotypes of PD and the scintigraphic pattern of 123 I-FP-CIT single photon emission computed tomography (SPECT). We examined 47 patients with early idiopathic PD (25 males; 22 females; mean age 58±2 years) and subdivided them in different clinical forms on the basis of dominance of resting tremor (n=20), bradykinesia plus rigidity (n=20) and the presence of both clinical signs [mixed type (MT, n=7)]. We correlated this status with the semi-quantitative analysis of SPECT with 123 I-FP-CIT. Tremor type patients showed a lower reduction of 123 I-FP-CIT uptake compared to akineticrigid type patients in contralateral caudate (P=0.0139) and putamen (P=0.0028) nuclei.
123I-FP-CIT uptake was higher in the ipsilateral caudate (P=0.0050) and putamen (P=0.0012) of tremor type patients compared to akinetic-rigid type patients. Comparisons of the striatal uptake in the tremor type and akinetic-rigid type patients with the MT patients revealed significant differences only in the ipsilateral and contralateral caudate. Our data indicate that in akinetic-rigid patients the dopaminergic system is more involved compared to that in the tremor type patients and that this difference is present from the initial stage of the disease. Moreover, our results suggest that PD phenotypes could be related not only to the dopaminergic involvement but also to other systems.
IntroductionThe relationships between movement disorders and the dopaminergic system have been extensively investigated, both in terms of presynaptic and postsynaptic processes (1). The particular interest in the dopamine active transporter (DAT) is related to the assessment of dopaminergic neuron loss in Parkinson's disease (PD) (2,3) and movement disorders (2,4,5).
123I-FP-CIT is a radiopharmaceutical highly selective for the DAT on the presynaptic processes of the nigrostriatal neurons (6). DAT is located on the plasma membrane of nerve terminals in a small number of neurons in the brain, especially in the striatum and nucleus accumbens, but also in the globus pallidus, cingulate cortex, olfactory tubercle, amygdala and midbrain (7).In idiopathic PD (IPD), 50% of patients complain of slowing up at presentation. The slowness of IPD involves both initiation and execution of movements, particularly sequential and volitional actions (8). About 40% of patients will complain of tremulousness of hands at rest, which improves with action and 80% of them will have an asymmetrical 3-5 Hz rest tremor evident on examination (9). A variant of IPD based on the clinical course is the mixed type (...